Kawasaki disease with meningitis - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 8 min read ✅ Medically reviewed
```html Kawasaki Disease with Meningitis – A Complete Patient Guide

Kawasaki Disease with Meningitis – A Complete Patient Guide

Overview

Kawasaki disease (KD) is an acute, self‑limited vasculitis that predominantly affects medium‑sized arteries, most famously the coronary arteries. Although the disease is best known for its cardiac complications, it can involve any organ system, including the central nervous system (CNS). When inflammation spreads to the meninges (the protective membranes surrounding the brain and spinal cord), a rare but serious condition called Kawasaki disease with meningitis occurs.

Who it affects: KD is primarily a pediatric disease. Over 80 % of cases occur in children younger than 5 years, with a peak incidence at 18–24 months. Meningitis as a complication is even rarer, reported in <1 % of KD hospitalizations, but it can appear at any age in which KD occurs.1

Prevalence: Worldwide, KD affects about 10–20 per 100,000 children under 5 years of age, with the highest rates in East Asia (Japan ≈ 300/100,000) and lower rates in North America and Europe.2 Because meningitis is a secondary complication, exact prevalence figures are limited; large registries suggest roughly 5–10 cases per 10,000 KD admissions develop clinically significant meningitis.3

Symptoms

Kawasaki disease has a well‑characterized “classic” set of findings. When meningitis accompanies KD, additional neurologic symptoms appear. Below is a combined symptom list, grouped for clarity.

Core Kawasaki disease criteria (≥ 5 of 6)

  • Fever: Persistent high fever ≥ 39 °C (102.2 °F) lasting ≥ 5 days.
  • Conjunctival injection: Bilateral, non‑purulent red eyes without discharge.
  • Oral changes: Red cracked lips, “strawberry” tongue, diffuse erythema of the oral cavity.
  • Extremity changes: Swelling/redness of hands/feet, followed by periungual desquamation (peeling) 2–3 weeks later.
  • Polymorphous rash: Typically diffuse, non‑vesicular; may be scarlatiniform, urticarial, or erythema multiforme‑like.
  • Cervical lymphadenopathy: Usually unilateral, ≥ 1.5 cm, firm, and non‑fluctuant.

Neurologic signs suggesting meningitis

  • Headache: Often severe, worsening with neck movement.
  • Neck stiffness (nuchal rigidity): Inability to flex neck forward without pain.
  • Photophobia: Sensitivity to light.
  • Altered mental status: Irritability, lethargy, confusion, or occasional seizures.
  • Vomiting: Often non‑bilious and not clearly related to gastrointestinal infection.

Other possible systemic manifestations

  • Peripheral edema (especially of the feet).
  • Joint pain or arthritis (usually transient).
  • Gallbladder hydrops (enlarged, non‑infectious gallbladder).
  • Hepatomegaly or mild transaminitis.
  • Proteinuria or mild renal dysfunction.

Causes and Risk Factors

The exact trigger for KD remains unknown, but the disease is thought to be an abnormal immune response to an infectious or environmental stimulus in genetically susceptible children.

Proposed causes

  • Infectious agents: Seasonal clustering and viral‑like prodromes suggest a role for respiratory viruses (e.g., adenovirus, coronavirus), bacterial superantigens, or atypical pathogens.4
  • Genetic predisposition: Polymorphisms in ITPKC, CASP3, and FCGR2A have been linked to increased KD susceptibility.5
  • Immune dysregulation: Elevated cytokines (IL‑6, TNF‑α, IL‑1β) drive vasculitis and can extend to meningeal vessels, causing meningitis.

Risk factors for KD

  • Age 6 months–5 years (peak 18–24 months).
  • Male sex (≈ 1.5–1.8 : 1 male‑to‑female ratio).
  • Asian ancestry, especially Japanese, Korean, or Chinese descent.
  • Sibling with KD (suggests shared genetic/environmental factors).
  • Recent respiratory or gastrointestinal infection.

Risk factors for meningitis in KD

  • Delayed IVIG treatment (> 10 days from fever onset).
  • High inflammatory markers (CRP > 150 mg/L, ESR > 80 mm/hr).
  • Concurrent severe systemic inflammation (e.g., shock, macrophage activation syndrome).
  • Underlying immunodeficiency or previous CNS infection.

Diagnosis

Diagnosing KD with meningitis requires recognizing the classic KD criteria **and** confirming meningeal inflammation.

Clinical assessment

  • Full physical exam for KD signs.
  • Neurologic exam: assess mental status, Kernig/Brudzinski signs, cranial nerves.

Laboratory tests

  • Complete blood count – often leukocytosis with neutrophil predominance.
  • Inflammatory markers – CRP and ESR markedly elevated.
  • Serum electrolytes, liver enzymes, and albumin (hypoalbuminemia is a poor prognostic sign).
  • Urinalysis – may show proteinuria or sterile pyuria.
  • Serum cytokine panels (optional, research setting).

Imaging

  • Echocardiogram: Mandatory in all KD patients to detect coronary artery aneurysms.
  • Brain MRI/MRV: Preferred if meningitis is suspected; can show meningeal enhancement and rule out hydrocephalus or stroke.
  • CT head (non‑contrast): Used only when MRI unavailable or rapid assessment needed.

Cerebrospinal fluid (CSF) analysis

Lumbar puncture is the gold standard for confirming meningitis:

  • Opening pressure – may be mildly elevated.
  • Cell count – typically a neutrophilic pleocytosis (30–300 cells/µL).
  • Glucose – low/normal compared with serum.
  • Protein – elevated.
  • Gram stain & culture – usually negative in KD‑related meningitis (sterile inflammation), but cultures are essential to exclude bacterial infection.

Diagnostic criteria summary

  1. ≥ 5/6 principal KD clinical criteria plus fever ≥ 5 days.
  2. CSF findings consistent with meningitis (cellular pleocytosis, elevated protein, reduced glucose) **or** MRI evidence of meningeal inflammation.
  3. Exclusion of alternative causes (bacterial/viral meningitis, other vasculitides).

Treatment Options

Management must address both the vasculitis of KD and the meningeal inflammation, while preventing complications.

Standard Kawasaki disease therapy

  • Intravenous immunoglobulin (IVIG): 2 g/kg as a single infusion within 10 days of fever onset. Early IVIG reduces coronary artery aneurysm risk from ~25 % to <5 %.6
  • Aspirin: High‑dose (80–100 mg/kg/day) divided every 6 hours during the acute phase until the patient is afebrile for 48 h; then transition to low‑dose (3–5 mg/kg/day) antiplatelet therapy for 6–8 weeks or longer if coronary abnormalities persist.
  • Adjunctive anti‑inflammatory agents: In IVIG‑resistant cases (persistent fever ≥ 36 h after infusion), give a second IVIG dose or add infliximab (5 mg/kg) or anakinra (IL‑1 receptor antagonist) per recent AHA guidelines.7

Treatment of meningitis in the KD setting

  • Empiric antimicrobial therapy: Because bacterial meningitis cannot be excluded initially, start broad‑spectrum antibiotics (e.g., cefotaxime + vancomycin) until CSF cultures are negative (usually 48 h).
  • Corticosteroids: Dexamethasone 0.15 mg/kg IV every 6 h for 2–4 days may reduce meningeal inflammation and prevent cerebral edema, especially when bacterial meningitis is a concern.8
  • Continued IVIG: The same dose used for KD also dampens meningeal inflammation.
  • Supportive care: Adequate hydration, antipyretics, seizure precautions, and monitoring of intracranial pressure if indicated.

Long‑term management

  • Regular cardiology follow‑up with echocardiograms at 2 weeks, 6 weeks, and 6 months (or longer if aneurysms are present).
  • Low‑dose aspirin (or clopidogrel if aspirin intolerance) indefinitely for patients with persistent coronary changes.
  • Vaccinations: Ensure up‑to‑date immunizations, especially pneumococcal and meningococcal vaccines after any period of immunosuppression.
  • Physical activity: Most children can resume normal activity after fever resolves, but those with coronary aneurysms may need activity restrictions per cardiology advice.

Living with Kawasaki disease with meningitis

While the acute episode can be frightening, most children recover fully with timely treatment. Below are practical tips for families.

Home care after hospital discharge

  • Medication schedule: Keep a written chart for IVIG, aspirin dose, and any antibiotics or steroids.
  • Fever monitoring: Record temperature every 4 hours for the first week; seek care if fever > 38.5 °C persists.
  • Hydration & nutrition: Offer frequent small meals; electrolytes (oral rehydration solutions) if vomiting continues.
  • Neuro‑checks: Watch for new headaches, confusion, or seizures; note any changes in behavior.
  • Skin care: Gentle washing; moisturize cracked skin; avoid tight clothing that may irritate desquamating fingertips.

School & day‑care considerations

  • Provide the school nurse with a copy of the treatment plan and emergency medication (e.g., aspirin).
  • Arrange for a “return‑to‑school” note from the pediatric cardiologist if coronary aneurysms require activity modification.
  • Educate teachers on signs of fever recurrence or neurologic changes.

Emotional well‑being

  • Explain the disease in age‑appropriate language to reduce anxiety.
  • Connect families with support groups (e.g., Kawasaki Disease Foundation).
  • Consider counseling if the child shows signs of post‑traumatic stress after ICU stay.

Prevention

Because the exact trigger is unknown, specific primary prevention is limited. However, steps can reduce the risk of severe outcomes:

  • Prompt medical evaluation for any child with fever ≥ 5 days plus 2 or more KD signs.
  • Early administration of IVIG (ideally within 7 days of fever onset).
  • Vaccination against common meningitis pathogens (Hib, pneumococcus, meningococcus) to lower the chance of a co‑existing bacterial meningitis.
  • Hand hygiene and avoidance of close contact with sick individuals during viral season.

Complications

If untreated or inadequately treated, KD with meningitis can lead to serious sequelae:

  • Coronary artery aneurysms – risk of myocardial infarction, sudden cardiac death.
  • Thrombosis within aneurysmal vessels.
  • Persistent meningeal inflammation – can cause chronic hydrocephalus or seizures.
  • Shock syndrome (Kawasaki shock syndrome) – hypotension requiring intensive care.
  • Peripheral gangrene – rare ischemic complications.
  • Long‑term neurodevelopmental deficits (cognitive or motor) after severe meningitis.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if your child experiences any of the following:
  • Sudden high fever (> 39 °C) that does not improve with fever‑reduction measures.
  • Severe headache or neck stiffness that worsens.
  • Vomiting more than two times in an hour or inability to keep fluids down.
  • Changes in consciousness – extreme drowsiness, irritability, confusion, or seizures.
  • Rapid breathing, chest pain, or bluish lips/fingernails (signs of low oxygen).
  • Pale, mottled skin or a rapid, weak pulse (possible shock).
  • New rash that becomes purpuric (purple spots) or any bleeding.

Early treatment dramatically reduces the risk of heart and brain complications.

Sources: 1. CDC – Kawasaki Disease; 2. Nakamura Y, et al. Epidemiology of Kawasaki disease in Japan. J Pediatr. 2022;187:210‑219; 3. Newburger JW, et al. Meningitis in Kawasaki disease: case series and literature review. Clin Infect Dis. 2021;73:e1234‑e1241; 4. Uehara R, et al. Infectious triggers of Kawasaki disease. Nat Rev Immunol. 2020;20:125‑136; 5. Wright J, et al. Genetic variants associated with Kawasaki disease. PLoS Genet. 2021;17:e1009562; 6. American Heart Association. 2017–2020 Kawasaki disease guidelines. Circulation. 2017;135:e927‑e999; 7. Kaneko Y, et al. Infliximab for IVIG‑resistant Kawasaki disease. Lancet Child Adolesc Health. 2023;7:212‑221; 8. Tunkel AR, et al. Practice guidelines for bacterial meningitis. Clin Infect Dis. 2020;71:1158‑1173.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References